Philips launches obstetrics monitoring solution to support clinicians and expectant mothers during COVID-19 pandemic
12 Junio 2020 - 07:00AM
Philips launches obstetrics monitoring solution to support
clinicians and expectant mothers during COVID-19 pandemic
June 12, 2020
- Under new April 2020 FDA guidance [1], the Avalon CL Fetal and
Maternal Pod and Patch are now available in the U.S., in addition
to existing countries in Europe, Australia, New Zealand and
Singapore, to support fetal and maternal monitoring
- Integrated with Philips’ comprehensive obstetrical care
portfolio, the new offering has the potential to reduce mother and
clinician risk of exposure to COVID-19, in hospital and in the
home
- Solution complements Philips innovative Remote Patient
Monitoring suite designed to transform care for at-risk
populations
Amsterdam, the Netherlands – Royal Philips (NYSE:
PHG, AEX: PHIA), a global leader in health technology, today
announced an addition to its remote patient monitoring suite
supporting at-risk populations during the COVID-19 emergency. The
new wireless Avalon CL Fetal and Maternal Pod and Patch aim to
reduce unnecessary physical interactions between clinicians and
patients, which is of particular importance during the COVID-19
pandemic. The patch is part of a broader innovative high-risk
pregnancy solution which includes Philips perinatal analytics, and
visualization software as well as an ultra-portable
battery-operated fetal monitor.
Up to half a million women may deliver their babies while
infected with COVID-19 in 2020. Additionally, pregnant women who
have not been diagnosed with COVID-19 are interested in ways they
can minimize their time in a hospital to limit their exposure to
the disease. While clinicians are treating COVID-19 patients in
isolation rooms, and accommodating home visits and births when
possible, properly managing patient care while reducing the risk of
exposure for care providers requires tools that enable remote
monitoring of vitals.
The Fetal and Maternal Pod and Patch allow for continuous,
non-invasive monitoring of maternal heart rate, fetal heart rate,
and uterine activity with a single-use, 48-hour, disposable
electrode patch placed on the mother’s abdomen. The patch is
designed to be placed on the patient by a clinician only once,
unlike traditional elastic belts and sensors that require frequent
repositioning.
“Remote monitoring during labor has always provided multiple
benefits to expectant mothers, including comfort, mobility, and
flexibility. But during the COVID-19 pandemic, the need for mobile
solutions during pregnancy is greater than ever,” said Peter Ziese,
General Manager, Monitoring & Analytics at Philips. “Philips
has been dedicated to providing the best quality care for expectant
mothers for more than fifty years. This new solution builds on our
commitment to provide integrated continuous monitoring capabilities
for high risk pregnancies. With this new patch, clinicians now have
access to an innovative tool to help monitor pregnant women during
COVID-19, helping to deliver comfort to these mothers during a
particularly stressful time.”
“The fact that the new sensors are disposable and don’t require
constant repositioning has been particularly useful for us in the
peak of the COVID-19 wave in March and April in Lisbon,” said Prof.
Dr. Diogo Ayres-de-Campos, University of Lisbon, and
President-Elect of the European Association of Perinatal Medicine
(EAPM).
The Philips OB solution consists of the Avalon Fetal monitoring
portfolio, featuring Philips proprietary Smart Pulse technology,
and an obstetrical information management system for continuous
data flow to the EMR, which includes:
- The Avalon Fetal and Maternal Pod and Patch: single-use
disposable patch and reusable pod placed on the expectant mother’s
abdomen to capture fetal and maternal heart rate, and uterine
activity through ECG and EMG signals, without the need for constant
repositioning;
- Avalon CL Transducer System: provides cableless monitoring with
the Avalon Fetal Monitors to give expectant mothers freedom to move
during labor, while measuring up to three fetuses. The Avalon CL
Wide Range Pod leverages the hospital’s wireless LAN installation
to allow mothers to expand the area of ambulation, by extending
monitoring of all cableless measurements to the full reach of the
WLAN.;
- IntelliSpace Perinatal: obstetrical surveillance and
information management system designed for use from antepartum
visit through labor, delivery, and postpartum care. Patient data
automatically displays and streams to the electronic medical record
(EMR). ISP Revision K in combination with IntelliVue XDS Remote
Display functionality offers the ability to control the Fetal
Monitor remotely.
The Avalon Fetal and Maternal Pod and Patch received CE Mark
clearance in 2019 and is available in many EU countries [2], as
well as Australia, New Zealand and Singapore.
Philips has a comprehensive portfolio of services and solutions
which can help to support the delivery of high-quality care to
COVID-19 patients. It includes secure, connected and intelligent
approaches to diagnosis, treatment and predictive monitoring in the
hospital, plus screening, remote patient monitoring and care at
home. With healthcare under more pressure than ever before,
Philips’ telehealth and AI-enabled data analytics can help support
workflows, facilitate remote collaboration and optimize resources.
Philips’ COVID-19-related solutions are designed for rapid
deployment and scalability. For more information on how Philips is
addressing COVID-19 globally, please visit the Philips centralized
COVID-19 hub.
[1] https://www.fda.gov/media/137286/download.[2] The Avalon
Fetal and Maternal Pod and Patch is available across Europe in the
Benelux, DACH, UK&I, Nordics, CEE and Iberia markets.
For more information, please contact: Kathy O’Reilly
Philips Global Press OfficeTel: +1 978-221-8919Email:
kathy.oreilly@philips.comTwitter: @kathyoreilly
Silvie CasanovaPhilips North AmericaTel: +1 978 659 7467E-mail:
Silvie.casanova@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2019
sales of EUR 19.5 billion and employs approximately 81,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- Avalon Fetal Monitoring Family in Room
- Avalon CL Fetal and Maternal Pod & Patch Close Up
- Avalon Fetal Monitoring Family Walking
Koninklijke Philips NV (EU:PHIA)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Koninklijke Philips NV (EU:PHIA)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024